71.01
price up icon2.72%   1.88
after-market Dopo l'orario di chiusura: 71.35 0.34 +0.48%
loading

Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
0.50%
57.17
56.89 41.94 53.57 55.39
Operating Income/Loss
0.50%
-57.17
-56.89 -41.94 -53.57 -55.39
Nonoperating Income/Loss
111.72%
-5.358
45.70 5.218 8.779 -13.62
Income/Loss From Continuing Operations Before Tax
459.15%
-62.53
-11.18 -36.72 -44.79 -69.01
Income Tax Expense/Benefit
-
- - -0.015 0.018
Income/Loss From Continuing Operations After Tax
459.15%
-62.53
-11.18 -36.72 -44.77 -69.03
Net Income/Loss
459.15%
-62.53
-11.18 -36.72 -44.77 -69.03
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):